Pharma & Healthcare
Global Recombinant Proteins Market Research Report 2025
- Apr 16, 25
- ID: 195721
- Pages: 90
- Figures: 89
- Views: 50
The global market for Recombinant Proteins was valued at US$ 1244 million in the year 2024 and is projected to reach a revised size of US$ 2896 million by 2031, growing at a CAGR of 13.0% during the forecast period.
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Global key manufacturers of recombinant proteins are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, and others. The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%. In terms of market size, Asia Pacific is the largest consumption market with more than 35% share. In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively. In terms of applications, biopharmaceutical companies are the top application area, with over 80% of the market share.
This report aims to provide a comprehensive presentation of the global market for Recombinant Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Proteins.
The Recombinant Proteins market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Proteins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Proteins companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Techne Corporation
Abcam PLC
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific
ACROBiosystems
Sino Biological
Cytiva
Eurogentec
GenScript Biotech Corporation
Reprocell
BPS Bioscience
Abnova Corporation
ProSpec Tany TechnoGene
Ajinomoto
Segment by Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Proteins company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Global key manufacturers of recombinant proteins are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, and others. The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%. In terms of market size, Asia Pacific is the largest consumption market with more than 35% share. In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively. In terms of applications, biopharmaceutical companies are the top application area, with over 80% of the market share.
This report aims to provide a comprehensive presentation of the global market for Recombinant Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Proteins.
The Recombinant Proteins market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Proteins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Proteins companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Techne Corporation
Abcam PLC
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific
ACROBiosystems
Sino Biological
Cytiva
Eurogentec
GenScript Biotech Corporation
Reprocell
BPS Bioscience
Abnova Corporation
ProSpec Tany TechnoGene
Ajinomoto
Segment by Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Proteins company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Proteins Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hormones
1.2.3 Growth Factors
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinant Metabolic Enzymes
1.2.7 Immune Checkpoint Regulators
1.2.8 Others
1.3 Market by Application
1.3.1 Global Recombinant Proteins Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Proteins Market Perspective (2020-2031)
2.2 Global Recombinant Proteins Growth Trends by Region
2.2.1 Global Recombinant Proteins Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant Proteins Historic Market Size by Region (2020-2025)
2.2.3 Recombinant Proteins Forecasted Market Size by Region (2026-2031)
2.3 Recombinant Proteins Market Dynamics
2.3.1 Recombinant Proteins Industry Trends
2.3.2 Recombinant Proteins Market Drivers
2.3.3 Recombinant Proteins Market Challenges
2.3.4 Recombinant Proteins Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Proteins Players by Revenue
3.1.1 Global Top Recombinant Proteins Players by Revenue (2020-2025)
3.1.2 Global Recombinant Proteins Revenue Market Share by Players (2020-2025)
3.2 Global Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Proteins Revenue
3.4 Global Recombinant Proteins Market Concentration Ratio
3.4.1 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Proteins Revenue in 2024
3.5 Global Key Players of Recombinant Proteins Head office and Area Served
3.6 Global Key Players of Recombinant Proteins, Product and Application
3.7 Global Key Players of Recombinant Proteins, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Proteins Breakdown Data by Type
4.1 Global Recombinant Proteins Historic Market Size by Type (2020-2025)
4.2 Global Recombinant Proteins Forecasted Market Size by Type (2026-2031)
5 Recombinant Proteins Breakdown Data by Application
5.1 Global Recombinant Proteins Historic Market Size by Application (2020-2025)
5.2 Global Recombinant Proteins Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant Proteins Market Size (2020-2031)
6.2 North America Recombinant Proteins Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant Proteins Market Size by Country (2020-2025)
6.4 North America Recombinant Proteins Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Proteins Market Size (2020-2031)
7.2 Europe Recombinant Proteins Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant Proteins Market Size by Country (2020-2025)
7.4 Europe Recombinant Proteins Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Proteins Market Size (2020-2031)
8.2 Asia-Pacific Recombinant Proteins Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant Proteins Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant Proteins Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Proteins Market Size (2020-2031)
9.2 Latin America Recombinant Proteins Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant Proteins Market Size by Country (2020-2025)
9.4 Latin America Recombinant Proteins Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Proteins Market Size (2020-2031)
10.2 Middle East & Africa Recombinant Proteins Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant Proteins Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant Proteins Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Techne Corporation
11.1.1 Bio-Techne Corporation Company Details
11.1.2 Bio-Techne Corporation Business Overview
11.1.3 Bio-Techne Corporation Recombinant Proteins Introduction
11.1.4 Bio-Techne Corporation Revenue in Recombinant Proteins Business (2020-2025)
11.1.5 Bio-Techne Corporation Recent Development
11.2 Abcam PLC
11.2.1 Abcam PLC Company Details
11.2.2 Abcam PLC Business Overview
11.2.3 Abcam PLC Recombinant Proteins Introduction
11.2.4 Abcam PLC Revenue in Recombinant Proteins Business (2020-2025)
11.2.5 Abcam PLC Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Recombinant Proteins Introduction
11.3.4 Merck KGaA Revenue in Recombinant Proteins Business (2020-2025)
11.3.5 Merck KGaA Recent Development
11.4 Miltenyi Biotec
11.4.1 Miltenyi Biotec Company Details
11.4.2 Miltenyi Biotec Business Overview
11.4.3 Miltenyi Biotec Recombinant Proteins Introduction
11.4.4 Miltenyi Biotec Revenue in Recombinant Proteins Business (2020-2025)
11.4.5 Miltenyi Biotec Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Recombinant Proteins Introduction
11.5.4 Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2020-2025)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 ACROBiosystems
11.6.1 ACROBiosystems Company Details
11.6.2 ACROBiosystems Business Overview
11.6.3 ACROBiosystems Recombinant Proteins Introduction
11.6.4 ACROBiosystems Revenue in Recombinant Proteins Business (2020-2025)
11.6.5 ACROBiosystems Recent Development
11.7 Sino Biological
11.7.1 Sino Biological Company Details
11.7.2 Sino Biological Business Overview
11.7.3 Sino Biological Recombinant Proteins Introduction
11.7.4 Sino Biological Revenue in Recombinant Proteins Business (2020-2025)
11.7.5 Sino Biological Recent Development
11.8 Cytiva
11.8.1 Cytiva Company Details
11.8.2 Cytiva Business Overview
11.8.3 Cytiva Recombinant Proteins Introduction
11.8.4 Cytiva Revenue in Recombinant Proteins Business (2020-2025)
11.8.5 Cytiva Recent Development
11.9 Eurogentec
11.9.1 Eurogentec Company Details
11.9.2 Eurogentec Business Overview
11.9.3 Eurogentec Recombinant Proteins Introduction
11.9.4 Eurogentec Revenue in Recombinant Proteins Business (2020-2025)
11.9.5 Eurogentec Recent Development
11.10 GenScript Biotech Corporation
11.10.1 GenScript Biotech Corporation Company Details
11.10.2 GenScript Biotech Corporation Business Overview
11.10.3 GenScript Biotech Corporation Recombinant Proteins Introduction
11.10.4 GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2020-2025)
11.10.5 GenScript Biotech Corporation Recent Development
11.11 Reprocell
11.11.1 Reprocell Company Details
11.11.2 Reprocell Business Overview
11.11.3 Reprocell Recombinant Proteins Introduction
11.11.4 Reprocell Revenue in Recombinant Proteins Business (2020-2025)
11.11.5 Reprocell Recent Development
11.12 BPS Bioscience
11.12.1 BPS Bioscience Company Details
11.12.2 BPS Bioscience Business Overview
11.12.3 BPS Bioscience Recombinant Proteins Introduction
11.12.4 BPS Bioscience Revenue in Recombinant Proteins Business (2020-2025)
11.12.5 BPS Bioscience Recent Development
11.13 Abnova Corporation
11.13.1 Abnova Corporation Company Details
11.13.2 Abnova Corporation Business Overview
11.13.3 Abnova Corporation Recombinant Proteins Introduction
11.13.4 Abnova Corporation Revenue in Recombinant Proteins Business (2020-2025)
11.13.5 Abnova Corporation Recent Development
11.14 ProSpec Tany TechnoGene
11.14.1 ProSpec Tany TechnoGene Company Details
11.14.2 ProSpec Tany TechnoGene Business Overview
11.14.3 ProSpec Tany TechnoGene Recombinant Proteins Introduction
11.14.4 ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2020-2025)
11.14.5 ProSpec Tany TechnoGene Recent Development
11.15 Ajinomoto
11.15.1 Ajinomoto Company Details
11.15.2 Ajinomoto Business Overview
11.15.3 Ajinomoto Recombinant Proteins Introduction
11.15.4 Ajinomoto Revenue in Recombinant Proteins Business (2020-2025)
11.15.5 Ajinomoto Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Proteins Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hormones
1.2.3 Growth Factors
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinant Metabolic Enzymes
1.2.7 Immune Checkpoint Regulators
1.2.8 Others
1.3 Market by Application
1.3.1 Global Recombinant Proteins Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Proteins Market Perspective (2020-2031)
2.2 Global Recombinant Proteins Growth Trends by Region
2.2.1 Global Recombinant Proteins Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant Proteins Historic Market Size by Region (2020-2025)
2.2.3 Recombinant Proteins Forecasted Market Size by Region (2026-2031)
2.3 Recombinant Proteins Market Dynamics
2.3.1 Recombinant Proteins Industry Trends
2.3.2 Recombinant Proteins Market Drivers
2.3.3 Recombinant Proteins Market Challenges
2.3.4 Recombinant Proteins Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Proteins Players by Revenue
3.1.1 Global Top Recombinant Proteins Players by Revenue (2020-2025)
3.1.2 Global Recombinant Proteins Revenue Market Share by Players (2020-2025)
3.2 Global Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Proteins Revenue
3.4 Global Recombinant Proteins Market Concentration Ratio
3.4.1 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Proteins Revenue in 2024
3.5 Global Key Players of Recombinant Proteins Head office and Area Served
3.6 Global Key Players of Recombinant Proteins, Product and Application
3.7 Global Key Players of Recombinant Proteins, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Proteins Breakdown Data by Type
4.1 Global Recombinant Proteins Historic Market Size by Type (2020-2025)
4.2 Global Recombinant Proteins Forecasted Market Size by Type (2026-2031)
5 Recombinant Proteins Breakdown Data by Application
5.1 Global Recombinant Proteins Historic Market Size by Application (2020-2025)
5.2 Global Recombinant Proteins Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant Proteins Market Size (2020-2031)
6.2 North America Recombinant Proteins Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant Proteins Market Size by Country (2020-2025)
6.4 North America Recombinant Proteins Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Proteins Market Size (2020-2031)
7.2 Europe Recombinant Proteins Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant Proteins Market Size by Country (2020-2025)
7.4 Europe Recombinant Proteins Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Proteins Market Size (2020-2031)
8.2 Asia-Pacific Recombinant Proteins Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant Proteins Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant Proteins Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Proteins Market Size (2020-2031)
9.2 Latin America Recombinant Proteins Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant Proteins Market Size by Country (2020-2025)
9.4 Latin America Recombinant Proteins Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Proteins Market Size (2020-2031)
10.2 Middle East & Africa Recombinant Proteins Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant Proteins Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant Proteins Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Techne Corporation
11.1.1 Bio-Techne Corporation Company Details
11.1.2 Bio-Techne Corporation Business Overview
11.1.3 Bio-Techne Corporation Recombinant Proteins Introduction
11.1.4 Bio-Techne Corporation Revenue in Recombinant Proteins Business (2020-2025)
11.1.5 Bio-Techne Corporation Recent Development
11.2 Abcam PLC
11.2.1 Abcam PLC Company Details
11.2.2 Abcam PLC Business Overview
11.2.3 Abcam PLC Recombinant Proteins Introduction
11.2.4 Abcam PLC Revenue in Recombinant Proteins Business (2020-2025)
11.2.5 Abcam PLC Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Recombinant Proteins Introduction
11.3.4 Merck KGaA Revenue in Recombinant Proteins Business (2020-2025)
11.3.5 Merck KGaA Recent Development
11.4 Miltenyi Biotec
11.4.1 Miltenyi Biotec Company Details
11.4.2 Miltenyi Biotec Business Overview
11.4.3 Miltenyi Biotec Recombinant Proteins Introduction
11.4.4 Miltenyi Biotec Revenue in Recombinant Proteins Business (2020-2025)
11.4.5 Miltenyi Biotec Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Recombinant Proteins Introduction
11.5.4 Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2020-2025)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 ACROBiosystems
11.6.1 ACROBiosystems Company Details
11.6.2 ACROBiosystems Business Overview
11.6.3 ACROBiosystems Recombinant Proteins Introduction
11.6.4 ACROBiosystems Revenue in Recombinant Proteins Business (2020-2025)
11.6.5 ACROBiosystems Recent Development
11.7 Sino Biological
11.7.1 Sino Biological Company Details
11.7.2 Sino Biological Business Overview
11.7.3 Sino Biological Recombinant Proteins Introduction
11.7.4 Sino Biological Revenue in Recombinant Proteins Business (2020-2025)
11.7.5 Sino Biological Recent Development
11.8 Cytiva
11.8.1 Cytiva Company Details
11.8.2 Cytiva Business Overview
11.8.3 Cytiva Recombinant Proteins Introduction
11.8.4 Cytiva Revenue in Recombinant Proteins Business (2020-2025)
11.8.5 Cytiva Recent Development
11.9 Eurogentec
11.9.1 Eurogentec Company Details
11.9.2 Eurogentec Business Overview
11.9.3 Eurogentec Recombinant Proteins Introduction
11.9.4 Eurogentec Revenue in Recombinant Proteins Business (2020-2025)
11.9.5 Eurogentec Recent Development
11.10 GenScript Biotech Corporation
11.10.1 GenScript Biotech Corporation Company Details
11.10.2 GenScript Biotech Corporation Business Overview
11.10.3 GenScript Biotech Corporation Recombinant Proteins Introduction
11.10.4 GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2020-2025)
11.10.5 GenScript Biotech Corporation Recent Development
11.11 Reprocell
11.11.1 Reprocell Company Details
11.11.2 Reprocell Business Overview
11.11.3 Reprocell Recombinant Proteins Introduction
11.11.4 Reprocell Revenue in Recombinant Proteins Business (2020-2025)
11.11.5 Reprocell Recent Development
11.12 BPS Bioscience
11.12.1 BPS Bioscience Company Details
11.12.2 BPS Bioscience Business Overview
11.12.3 BPS Bioscience Recombinant Proteins Introduction
11.12.4 BPS Bioscience Revenue in Recombinant Proteins Business (2020-2025)
11.12.5 BPS Bioscience Recent Development
11.13 Abnova Corporation
11.13.1 Abnova Corporation Company Details
11.13.2 Abnova Corporation Business Overview
11.13.3 Abnova Corporation Recombinant Proteins Introduction
11.13.4 Abnova Corporation Revenue in Recombinant Proteins Business (2020-2025)
11.13.5 Abnova Corporation Recent Development
11.14 ProSpec Tany TechnoGene
11.14.1 ProSpec Tany TechnoGene Company Details
11.14.2 ProSpec Tany TechnoGene Business Overview
11.14.3 ProSpec Tany TechnoGene Recombinant Proteins Introduction
11.14.4 ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2020-2025)
11.14.5 ProSpec Tany TechnoGene Recent Development
11.15 Ajinomoto
11.15.1 Ajinomoto Company Details
11.15.2 Ajinomoto Business Overview
11.15.3 Ajinomoto Recombinant Proteins Introduction
11.15.4 Ajinomoto Revenue in Recombinant Proteins Business (2020-2025)
11.15.5 Ajinomoto Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Recombinant Proteins Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hormones
Table 3. Key Players of Growth Factors
Table 4. Key Players of Cytokines
Table 5. Key Players of Plasma Protein Factor
Table 6. Key Players of Recombinant Metabolic Enzymes
Table 7. Key Players of Immune Checkpoint Regulators
Table 8. Key Players of Others
Table 9. Global Recombinant Proteins Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Recombinant Proteins Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Recombinant Proteins Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Recombinant Proteins Market Share by Region (2020-2025)
Table 13. Global Recombinant Proteins Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Recombinant Proteins Market Share by Region (2026-2031)
Table 15. Recombinant Proteins Market Trends
Table 16. Recombinant Proteins Market Drivers
Table 17. Recombinant Proteins Market Challenges
Table 18. Recombinant Proteins Market Restraints
Table 19. Global Recombinant Proteins Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Recombinant Proteins Market Share by Players (2020-2025)
Table 21. Global Top Recombinant Proteins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Proteins as of 2024)
Table 22. Ranking of Global Top Recombinant Proteins Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Recombinant Proteins Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Recombinant Proteins, Headquarters and Area Served
Table 25. Global Key Players of Recombinant Proteins, Product and Application
Table 26. Global Key Players of Recombinant Proteins, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Recombinant Proteins Revenue Market Share by Type (2020-2025)
Table 30. Global Recombinant Proteins Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Recombinant Proteins Revenue Market Share by Type (2026-2031)
Table 32. Global Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Recombinant Proteins Revenue Market Share by Application (2020-2025)
Table 34. Global Recombinant Proteins Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Recombinant Proteins Revenue Market Share by Application (2026-2031)
Table 36. North America Recombinant Proteins Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Recombinant Proteins Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Recombinant Proteins Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Recombinant Proteins Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Recombinant Proteins Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Recombinant Proteins Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Recombinant Proteins Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Recombinant Proteins Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Recombinant Proteins Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Recombinant Proteins Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Recombinant Proteins Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Recombinant Proteins Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Recombinant Proteins Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Recombinant Proteins Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Recombinant Proteins Market Size by Country (2026-2031) & (US$ Million)
Table 51. Bio-Techne Corporation Company Details
Table 52. Bio-Techne Corporation Business Overview
Table 53. Bio-Techne Corporation Recombinant Proteins Product
Table 54. Bio-Techne Corporation Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 55. Bio-Techne Corporation Recent Development
Table 56. Abcam PLC Company Details
Table 57. Abcam PLC Business Overview
Table 58. Abcam PLC Recombinant Proteins Product
Table 59. Abcam PLC Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 60. Abcam PLC Recent Development
Table 61. Merck KGaA Company Details
Table 62. Merck KGaA Business Overview
Table 63. Merck KGaA Recombinant Proteins Product
Table 64. Merck KGaA Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 65. Merck KGaA Recent Development
Table 66. Miltenyi Biotec Company Details
Table 67. Miltenyi Biotec Business Overview
Table 68. Miltenyi Biotec Recombinant Proteins Product
Table 69. Miltenyi Biotec Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 70. Miltenyi Biotec Recent Development
Table 71. Thermo Fisher Scientific Company Details
Table 72. Thermo Fisher Scientific Business Overview
Table 73. Thermo Fisher Scientific Recombinant Proteins Product
Table 74. Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 75. Thermo Fisher Scientific Recent Development
Table 76. ACROBiosystems Company Details
Table 77. ACROBiosystems Business Overview
Table 78. ACROBiosystems Recombinant Proteins Product
Table 79. ACROBiosystems Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 80. ACROBiosystems Recent Development
Table 81. Sino Biological Company Details
Table 82. Sino Biological Business Overview
Table 83. Sino Biological Recombinant Proteins Product
Table 84. Sino Biological Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 85. Sino Biological Recent Development
Table 86. Cytiva Company Details
Table 87. Cytiva Business Overview
Table 88. Cytiva Recombinant Proteins Product
Table 89. Cytiva Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 90. Cytiva Recent Development
Table 91. Eurogentec Company Details
Table 92. Eurogentec Business Overview
Table 93. Eurogentec Recombinant Proteins Product
Table 94. Eurogentec Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 95. Eurogentec Recent Development
Table 96. GenScript Biotech Corporation Company Details
Table 97. GenScript Biotech Corporation Business Overview
Table 98. GenScript Biotech Corporation Recombinant Proteins Product
Table 99. GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 100. GenScript Biotech Corporation Recent Development
Table 101. Reprocell Company Details
Table 102. Reprocell Business Overview
Table 103. Reprocell Recombinant Proteins Product
Table 104. Reprocell Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 105. Reprocell Recent Development
Table 106. BPS Bioscience Company Details
Table 107. BPS Bioscience Business Overview
Table 108. BPS Bioscience Recombinant Proteins Product
Table 109. BPS Bioscience Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 110. BPS Bioscience Recent Development
Table 111. Abnova Corporation Company Details
Table 112. Abnova Corporation Business Overview
Table 113. Abnova Corporation Recombinant Proteins Product
Table 114. Abnova Corporation Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 115. Abnova Corporation Recent Development
Table 116. ProSpec Tany TechnoGene Company Details
Table 117. ProSpec Tany TechnoGene Business Overview
Table 118. ProSpec Tany TechnoGene Recombinant Proteins Product
Table 119. ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 120. ProSpec Tany TechnoGene Recent Development
Table 121. Ajinomoto Company Details
Table 122. Ajinomoto Business Overview
Table 123. Ajinomoto Recombinant Proteins Product
Table 124. Ajinomoto Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 125. Ajinomoto Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Recombinant Proteins Picture
Figure 2. Global Recombinant Proteins Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Proteins Market Share by Type: 2024 VS 2031
Figure 4. Hormones Features
Figure 5. Growth Factors Features
Figure 6. Cytokines Features
Figure 7. Plasma Protein Factor Features
Figure 8. Recombinant Metabolic Enzymes Features
Figure 9. Immune Checkpoint Regulators Features
Figure 10. Others Features
Figure 11. Global Recombinant Proteins Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Recombinant Proteins Market Share by Application: 2024 VS 2031
Figure 13. Biopharmaceutical Companies Case Studies
Figure 14. Academic and Research Institutes Case Studies
Figure 15. Contract Research Organizations Case Studies
Figure 16. Recombinant Proteins Report Years Considered
Figure 17. Global Recombinant Proteins Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Recombinant Proteins Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Recombinant Proteins Market Share by Region: 2024 VS 2031
Figure 20. Global Recombinant Proteins Market Share by Players in 2024
Figure 21. Global Top Recombinant Proteins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Proteins as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Recombinant Proteins Revenue in 2024
Figure 23. North America Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Recombinant Proteins Market Share by Country (2020-2031)
Figure 25. United States Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Recombinant Proteins Market Share by Country (2020-2031)
Figure 29. Germany Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Recombinant Proteins Market Share by Region (2020-2031)
Figure 37. China Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Recombinant Proteins Market Share by Country (2020-2031)
Figure 45. Mexico Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Recombinant Proteins Market Share by Country (2020-2031)
Figure 49. Turkey Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Bio-Techne Corporation Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 53. Abcam PLC Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 54. Merck KGaA Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 55. Miltenyi Biotec Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 57. ACROBiosystems Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 58. Sino Biological Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 59. Cytiva Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 60. Eurogentec Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 61. GenScript Biotech Corporation Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 62. Reprocell Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 63. BPS Bioscience Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 64. Abnova Corporation Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 65. ProSpec Tany TechnoGene Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 66. Ajinomoto Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Recombinant Proteins Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hormones
Table 3. Key Players of Growth Factors
Table 4. Key Players of Cytokines
Table 5. Key Players of Plasma Protein Factor
Table 6. Key Players of Recombinant Metabolic Enzymes
Table 7. Key Players of Immune Checkpoint Regulators
Table 8. Key Players of Others
Table 9. Global Recombinant Proteins Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Recombinant Proteins Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Recombinant Proteins Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Recombinant Proteins Market Share by Region (2020-2025)
Table 13. Global Recombinant Proteins Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Recombinant Proteins Market Share by Region (2026-2031)
Table 15. Recombinant Proteins Market Trends
Table 16. Recombinant Proteins Market Drivers
Table 17. Recombinant Proteins Market Challenges
Table 18. Recombinant Proteins Market Restraints
Table 19. Global Recombinant Proteins Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Recombinant Proteins Market Share by Players (2020-2025)
Table 21. Global Top Recombinant Proteins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Proteins as of 2024)
Table 22. Ranking of Global Top Recombinant Proteins Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Recombinant Proteins Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Recombinant Proteins, Headquarters and Area Served
Table 25. Global Key Players of Recombinant Proteins, Product and Application
Table 26. Global Key Players of Recombinant Proteins, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Recombinant Proteins Revenue Market Share by Type (2020-2025)
Table 30. Global Recombinant Proteins Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Recombinant Proteins Revenue Market Share by Type (2026-2031)
Table 32. Global Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Recombinant Proteins Revenue Market Share by Application (2020-2025)
Table 34. Global Recombinant Proteins Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Recombinant Proteins Revenue Market Share by Application (2026-2031)
Table 36. North America Recombinant Proteins Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Recombinant Proteins Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Recombinant Proteins Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Recombinant Proteins Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Recombinant Proteins Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Recombinant Proteins Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Recombinant Proteins Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Recombinant Proteins Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Recombinant Proteins Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Recombinant Proteins Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Recombinant Proteins Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Recombinant Proteins Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Recombinant Proteins Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Recombinant Proteins Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Recombinant Proteins Market Size by Country (2026-2031) & (US$ Million)
Table 51. Bio-Techne Corporation Company Details
Table 52. Bio-Techne Corporation Business Overview
Table 53. Bio-Techne Corporation Recombinant Proteins Product
Table 54. Bio-Techne Corporation Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 55. Bio-Techne Corporation Recent Development
Table 56. Abcam PLC Company Details
Table 57. Abcam PLC Business Overview
Table 58. Abcam PLC Recombinant Proteins Product
Table 59. Abcam PLC Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 60. Abcam PLC Recent Development
Table 61. Merck KGaA Company Details
Table 62. Merck KGaA Business Overview
Table 63. Merck KGaA Recombinant Proteins Product
Table 64. Merck KGaA Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 65. Merck KGaA Recent Development
Table 66. Miltenyi Biotec Company Details
Table 67. Miltenyi Biotec Business Overview
Table 68. Miltenyi Biotec Recombinant Proteins Product
Table 69. Miltenyi Biotec Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 70. Miltenyi Biotec Recent Development
Table 71. Thermo Fisher Scientific Company Details
Table 72. Thermo Fisher Scientific Business Overview
Table 73. Thermo Fisher Scientific Recombinant Proteins Product
Table 74. Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 75. Thermo Fisher Scientific Recent Development
Table 76. ACROBiosystems Company Details
Table 77. ACROBiosystems Business Overview
Table 78. ACROBiosystems Recombinant Proteins Product
Table 79. ACROBiosystems Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 80. ACROBiosystems Recent Development
Table 81. Sino Biological Company Details
Table 82. Sino Biological Business Overview
Table 83. Sino Biological Recombinant Proteins Product
Table 84. Sino Biological Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 85. Sino Biological Recent Development
Table 86. Cytiva Company Details
Table 87. Cytiva Business Overview
Table 88. Cytiva Recombinant Proteins Product
Table 89. Cytiva Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 90. Cytiva Recent Development
Table 91. Eurogentec Company Details
Table 92. Eurogentec Business Overview
Table 93. Eurogentec Recombinant Proteins Product
Table 94. Eurogentec Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 95. Eurogentec Recent Development
Table 96. GenScript Biotech Corporation Company Details
Table 97. GenScript Biotech Corporation Business Overview
Table 98. GenScript Biotech Corporation Recombinant Proteins Product
Table 99. GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 100. GenScript Biotech Corporation Recent Development
Table 101. Reprocell Company Details
Table 102. Reprocell Business Overview
Table 103. Reprocell Recombinant Proteins Product
Table 104. Reprocell Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 105. Reprocell Recent Development
Table 106. BPS Bioscience Company Details
Table 107. BPS Bioscience Business Overview
Table 108. BPS Bioscience Recombinant Proteins Product
Table 109. BPS Bioscience Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 110. BPS Bioscience Recent Development
Table 111. Abnova Corporation Company Details
Table 112. Abnova Corporation Business Overview
Table 113. Abnova Corporation Recombinant Proteins Product
Table 114. Abnova Corporation Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 115. Abnova Corporation Recent Development
Table 116. ProSpec Tany TechnoGene Company Details
Table 117. ProSpec Tany TechnoGene Business Overview
Table 118. ProSpec Tany TechnoGene Recombinant Proteins Product
Table 119. ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 120. ProSpec Tany TechnoGene Recent Development
Table 121. Ajinomoto Company Details
Table 122. Ajinomoto Business Overview
Table 123. Ajinomoto Recombinant Proteins Product
Table 124. Ajinomoto Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 125. Ajinomoto Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Recombinant Proteins Picture
Figure 2. Global Recombinant Proteins Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Proteins Market Share by Type: 2024 VS 2031
Figure 4. Hormones Features
Figure 5. Growth Factors Features
Figure 6. Cytokines Features
Figure 7. Plasma Protein Factor Features
Figure 8. Recombinant Metabolic Enzymes Features
Figure 9. Immune Checkpoint Regulators Features
Figure 10. Others Features
Figure 11. Global Recombinant Proteins Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Recombinant Proteins Market Share by Application: 2024 VS 2031
Figure 13. Biopharmaceutical Companies Case Studies
Figure 14. Academic and Research Institutes Case Studies
Figure 15. Contract Research Organizations Case Studies
Figure 16. Recombinant Proteins Report Years Considered
Figure 17. Global Recombinant Proteins Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Recombinant Proteins Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Recombinant Proteins Market Share by Region: 2024 VS 2031
Figure 20. Global Recombinant Proteins Market Share by Players in 2024
Figure 21. Global Top Recombinant Proteins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Proteins as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Recombinant Proteins Revenue in 2024
Figure 23. North America Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Recombinant Proteins Market Share by Country (2020-2031)
Figure 25. United States Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Recombinant Proteins Market Share by Country (2020-2031)
Figure 29. Germany Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Recombinant Proteins Market Share by Region (2020-2031)
Figure 37. China Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Recombinant Proteins Market Share by Country (2020-2031)
Figure 45. Mexico Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Recombinant Proteins Market Share by Country (2020-2031)
Figure 49. Turkey Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Recombinant Proteins Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Bio-Techne Corporation Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 53. Abcam PLC Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 54. Merck KGaA Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 55. Miltenyi Biotec Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 57. ACROBiosystems Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 58. Sino Biological Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 59. Cytiva Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 60. Eurogentec Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 61. GenScript Biotech Corporation Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 62. Reprocell Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 63. BPS Bioscience Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 64. Abnova Corporation Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 65. ProSpec Tany TechnoGene Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 66. Ajinomoto Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232